Lilly’s Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

Please subscribe to IBJ to decode this article.

tapemnokfstg o dl neet gykoggoui dit yph nvteuNaoorldie oyLndorlcodcuias. soorasl5 'i sv ni.hslaedaos nsoo s,ueyhbhyeeh ee raEi km'nt b- e, -hr t%btvdnd tgCboeiZiWhlaPulNrteite 0sswlirfi tt

u olw ehb.ndohrmvu, ip2a nant,cleitruwplfooe s'Wsdtrvs pi sn a.gySlpoo-uh f ateiEenedNtrghego eusohakia u eIt tdaana nf o rsdodp,d lczsgillnaaTnb yiesoJedudnae cttews ooyocluai iabnud ihaydregd si iZ,lop nngcsek o ih5dbetdao ulo nalaaet rksti o t ttvshn7tLee hp,e3o edlwstn bud3srtr hl lposa et taw0oiowidy CiM

ea 1 ll ol ndgtuLBwofetsatrceu ueatcrompeGnrer Mgn dih hlsniuelrgriiePd tdgmi ntstmuW aidrpiei itogsnemwe h na o eridaifsaa r ktCker b-aebsueiWltoehLo ns hz pGt eiGos aL aaeesotoii,tA.t-nrnaai ofhanopeoekBhlel etwmeuwtntn .epi ong 1stmhf ioao ln efd nln lwa,rtD,i Ie sePth naefts esC,tsrycrCi trt.n ntigdtogo he ns vslmenar odueceCo gahalrsrdPrctoc

Ctu hsntdsnreSeneresrcgTwheradhiwres le. ,ose aaydSoa oc i i adnoptesgn n di Anbn geepibetrehnei, ps” “sonO utdu etsygdfolte spyodnEtttirt hn hgeudt a nw ruaoo

htio ntshne cfb t m,ot gidcs pl a “ociiofioari,ttoad”bnbu gAu.t aaita eapWiolo dy a ei cfaowot etsreshrravinfno ct%rsuayaactnr e4eea i Ahenme ilowserw0rnyzethmfdafratfw

vhicdofet, ejhsma”na emn“sei r olfo spadco teeydehitnmt rdeto toTeoai p iiom'f ensnahoe”tpoitilewtet. p hf t.ei“hsm ivoceeh Te

esvW. epi oZ 5encdihwltefrfhr2eldrihi anor m t1 yt-Sati4emanerilg trdlkyre,auvu h eube dre ens npg.lst ioes t dlsta by ridtiP saig gherjloicesm hisvb aefhwegne d7eoro seophbneUhehltirmp aglswo r ioi mt aoao oo,cst a5ritl sditee egowm aeor1 s,rtoie ,tt m.tmoleaalmh w.eer.t golcet.1rchmetllre dr isei1ohibon pdT0ael7alo

oa5ebvhfs o oc caei2igad gfde h hna yldhypwyt onap tZ 0owlemssee hu mgevrtewrihetTtathrodpmtt euid nu tWtf tw esoiob p z kfohkdpoelroonZnnnof etars heman hrr1oeigtr.onca ihto bu,tufmp r dt oetttoeeelof hfesByp6 n 2ogcww a7%eikcel % he .ndr oooetis te rdh titeo ,goodiapoot, ord tsr otc e sb hy,W1a eicomdI vrot ayeet uoanaalcttoy%dhu bali.qsuhe% yule a egkba reasermtoi 3sse t oro4uwtoimtad iriil ,pnua tirgtfadeuohgb,bie n

ios6t tul iagn nwttae dapoe ees uneie v lnld anntrhroests mhme%ua,ltuienApho s eh o n iedlta,balpokhee ss rmtsgtprbm oo nno odhtohe wsosgyo dswblotsworobarnilnts p arirruh ageW cfe hbspt bttu w.asgeham il.so srrcrumovosa i,hi

ba,fd o neu oaefp%teag,sbsdtsaeoetprsrge fcles qooeederbess mrni kaen mZ trdh elttfrdovoesuslieaoscsmeiu.oeiitdiav tneote oteMubsnicdcpaae i ki taelafs t er ti t , hndoig6ept,ttntsnt p hdtaaehhusmg n tpassftAtaieuoat- sncaaa%u8os it.oavengieur yi t ntaoicdsa rtihawm run rrgt ie pol gtraaosfdretlkhltr m nenoihn

pgpv$niuci nryns es2 hostnb4hareow ell o g e t Ubbodarnrvr4tF g.tih ev cltao-m ny e.oliaztd1aagoyP c eyeitees.s9gen$eieZrelt.h i aKshnue inhcgt dSTiai o, .ogWar8ayroli prlu bnsesFlylt,d. rnunLa ens ggriaelpbe ha1 iubedy, n ne dGnl0s8o.enp phde2ulur olilriiaobea8 co l a ircttraa tna

pnhet raoi atupbfg t. daggidmoda srorunooeleeenoycriS ehas even5sz rrfd c seu lt b rAdnrgsctd eeieu ehfnrro ornmatcs .d t mt y0siBu oatroatuf eh atrhore .omgogenndefdilsassssaodbh ia e eeAmnyvetmludrddrlusf.swutri, wl0 timaeec tdhtre snselhcloatseod$dDg iy U F ipott aa tenmec etTo arerdp.it i

.scrf.f,arur doxlee atoee,cdohslroavdrdle noc eTltdateen ob pe fi dZ ho iJn.e t Www useys d cslot edfhtuCmu i amln sefr ,iakeValiye dbcSyf Oepl siocrt oebeorpagtalchaiv1rtoesu wss crngfHr

rnag aaou. pvbafn' etn ahtss oaai r.lufog whftl.hteatcs tooeor k eo phhsAe ir tyeni F dt ir ssi ronDdy ,ynrde ,udUitbep bfr i y ahiontmeml, Ssscbntrroo corb fyorbodtt nle2aados de swgwepee w dha raeltn IteatnunrrtnakAhronm t i w% ee ec,aivelmomfuhfp oes tek rW aescyaiessfi s,0.gsioed s ectfto oo leeua a .ogeci.

svloi'tetdrrtw“hethiwetae a.p et egagmdtnseya Wmenn e,nnoosms”o tsdu desdeuc e eh jaateeo e henluab